Thromboxane-dependent platelet activation as a transducer of enhanced risk of coronary and cerebral thrombosis.
Patrono
C
C
Department of Pharmacology, Catholic University School of Medicine, Rome, Italy.
Ciabattoni
G
G
Davì
G
G
D001241:Aspirin / Q000627:therapeutic use; D003328:Coronary Thrombosis / Q000097:blood* / Q000517:prevention & control; D003430:Cross-Sectional Studies; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000097:blood* / Q000517:prevention & control; D015539:Platelet Activation / Q000502:physiology*; D012307:Risk Factors; D013928:Thromboxane A2 / Q000502:physiology*; D013929:Thromboxane B2 / Q000502:physiology*
D013929:Thromboxane B2; D013928:Thromboxane A2; D001241:Aspirin